Forte Biosciences, Inc. (FBRX)
76.99
0.00 (0.00%)
USD |
NASDAQ |
Oct 06, 16:00
Forte Biosciences Market Cap : 1.577B for Oct. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 06, 2026 | 1.577B |
| October 05, 2026 | 1.577B |
| October 02, 2026 | 1.577B |
| October 01, 2026 | 1.577B |
| September 30, 2026 | 1.577B |
| September 29, 2026 | 1.577B |
| September 28, 2026 | 1.577B |
| September 25, 2026 | 1.577B |
| September 24, 2026 | 1.577B |
| September 23, 2026 | 1.577B |
| September 22, 2026 | 1.577B |
| September 21, 2026 | 1.577B |
| September 18, 2026 | 1.577B |
| September 17, 2026 | 1.577B |
| September 16, 2026 | 1.577B |
| September 15, 2026 | 1.577B |
| September 14, 2026 | 1.577B |
| September 11, 2026 | 1.577B |
| September 10, 2026 | 1.577B |
| September 09, 2026 | 1.577B |
| September 08, 2026 | 1.577B |
| September 04, 2026 | 1.577B |
| September 03, 2026 | 1.577B |
| September 02, 2026 | 1.577B |
| September 01, 2026 | 1.577B |
| Date | Value |
|---|---|
| August 31, 2026 | 1.577B |
| August 28, 2026 | 1.577B |
| August 27, 2026 | 1.577B |
| August 26, 2026 | 1.577B |
| August 25, 2026 | 1.577B |
| August 24, 2026 | 1.576B |
| August 21, 2026 | 1.576B |
| August 20, 2026 | 1.575B |
| August 19, 2026 | 1.575B |
| August 18, 2026 | 1.575B |
| August 17, 2026 | 1.575B |
| August 14, 2026 | 1.574B |
| August 13, 2026 | 1.574B |
| August 12, 2026 | 1.573B |
| August 11, 2026 | 1.574B |
| August 10, 2026 | 1.573B |
| August 07, 2026 | 1.068B |
| August 06, 2026 | 1.069B |
| August 05, 2026 | 1.066B |
| August 04, 2026 | 1.065B |
| August 03, 2026 | 1.066B |
| July 31, 2026 | 1.066B |
| July 30, 2026 | 1.071B |
| July 29, 2026 | 1.065B |
| July 28, 2026 | 1.066B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| argenx SE | 57.89B |
| ACADIA Pharmaceuticals, Inc. | 3.381B |
| Alnylam Pharmaceuticals, Inc. | 30.60B |
| Savara, Inc. | 1.023B |
| Vericel Corp. | 2.066B |
Market Cap Related Metrics
| Price to Book Value | 8.580 |
| Price | 76.99 |
| Earnings Yield | -6.66% |